A new cancer drug based on doxorubicin, designed to deliver the substance directly to tumors, has been developed in Russia, RIA Novosti reports, citing Deputy Prime Minister Tatiana Golikova. The drug is said to be "safer for the heart's function and capable of allowing more effective drug treatment." Its use is expected to begin in 2029.

A new cancer drug based on doxorubicin, designed to deliver the substance directly to tumors, has been developed in Russia, RIA Novosti reports, citing Deputy Prime Minister Tatiana Golikova. The drug is said to be "safer for the heart's function and capable of allowing more effective drug treatment." Its use is expected to begin in 2029.